Background Cancer of the breast is one of the most dreaded diseases among women. Maspin is a novel member of the serine proteinase inhibitor family, which has a tumour suppressor activity. The aim of the present work was to correlate the expression of Maspin with established prognostic factors of breast carcinoma and with microvessel density as measured by CD31.
Materials and methods Maspin and CD31immunostaining procedures were performed on 75 specimens of breast carcinoma obtained by surgery and on five normal breast tissue specimens obtained by reduction mammoplasty.
ResultsThere was a statistically significant difference between the Maspin-positive and Maspin-negative groups with regard to tumour growth pattern (P < 0.001), tumour size (P = 0.014), grade (P = 0.031), lymph node metastasis (P = 0.001), tumour stage (P = 0.033), hormonal receptor status (oestrogen receptor and progesterone receptor: P = 0.027 and P < 0.008, respectively) and Her2/neu expression (P = 0.011). Triple-negative cases were highly associated with the Maspin-positive group (P < 0.001). The increase in Maspin positivity was significantly associated with a decrease in microvessel density in tumour tissue (P < 0.001).Conclusion Maspin could be considered an independent poor prognostic marker for breast carcinoma.